Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Facciabene

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Cancer Research|August 14, 2023
Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy ResistanceRenzo Perales-Linares, Nektaria Maria Leli, Hesham Mohei, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
Science Advances|January 1, 2026
HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumorsDaniel Hwang, Molly C Erdman, Santosh Adhikari, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot studySteven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2023
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapyMireia Uribe-Herranz, Silvia Beghi, Marco Ruella, et al.
Nature Medicine|March 15, 2022
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Nature Medicine|October 17, 2022
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Cancer Research|August 14, 2023
Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy ResistanceRenzo Perales-Linares, Nektaria Maria Leli, Hesham Mohei, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
Science Advances|January 1, 2026
HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumorsDaniel Hwang, Molly C Erdman, Santosh Adhikari, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot studySteven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2023
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapyMireia Uribe-Herranz, Silvia Beghi, Marco Ruella, et al.
Nature Medicine|March 15, 2022
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Nature Medicine|October 17, 2022
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Pageof 5